NCI Center for Cancer Research shared a post on LinkedIn:
“Congratulations to Dr. Nirali Shah from our Pediatric Oncology Branch for her election to the American Society of Clinical Investigation!
Dr. Shah’s research focuses on the development of targeted immunotherapy approaches to treat high-risk blood cancers, such as leukemia and lymphoma, in children, adolescents, and young adults. She is also interested in the prevention and treatment of relapsed disease after allogeneic hematopoietic stem cell transplantation.
Learn more about Dr. Shah and her open clinical trials.”
More posts featuring NCI Center for Cancer Research.